Oracle Investment Management as of Dec. 31, 2014
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 28 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 13.7 | $104M | 5.4M | 19.19 | |
| Quidel Corporation | 11.1 | $84M | 2.9M | 28.92 | |
| NxStage Medical | 8.8 | $67M | 3.8M | 17.93 | |
| Tenet Healthcare Corporation | 8.6 | $66M | 1.3M | 50.67 | |
| Opko Health (OPK) | 6.9 | $53M | 5.3M | 9.99 | |
| Acorda Therapeutics | 5.5 | $42M | 1.0M | 40.87 | |
| Thoratec Corporation | 5.2 | $40M | 1.2M | 32.46 | |
| Chimerix (CMRX) | 5.1 | $39M | 969k | 40.26 | |
| Transition Therapeutics | 4.4 | $33M | 4.9M | 6.84 | |
| Accuray Incorporated (ARAY) | 3.6 | $28M | 3.7M | 7.55 | |
| Biolase Technology | 3.6 | $27M | 11M | 2.62 | |
| Mazor Robotics Ltd. equities | 3.5 | $26M | 2.1M | 12.41 | |
| Pacific Biosciences of California (PACB) | 3.3 | $25M | 3.2M | 7.84 | |
| Tesaro | 2.7 | $21M | 556k | 37.19 | |
| Raptor Pharmaceutical | 2.7 | $20M | 1.9M | 10.52 | |
| Vermillion | 2.1 | $16M | 8.1M | 1.99 | |
| Hansen Medical | 1.9 | $15M | 26M | 0.56 | |
| Intrexon | 1.3 | $10M | 369k | 27.53 | |
| WebMD Health | 1.2 | $9.4M | 238k | 39.55 | |
| Plasmatech Biopharmaceutical | 1.2 | $9.3M | 2.7M | 3.45 | |
| Cerus Corporation (CERS) | 0.8 | $6.4M | 1.0M | 6.24 | |
| Amarin Corporation (AMRN) | 0.7 | $5.1M | 5.2M | 0.98 | |
| shares Agenus | 0.6 | $4.6M | 1.2M | 3.97 | |
| Second Sight Med Prods | 0.6 | $4.4M | 432k | 10.26 | |
| Metabolix | 0.4 | $3.3M | 8.0M | 0.41 | |
| Biogen Idec (BIIB) | 0.3 | $2.6M | 7.7k | 339.51 | |
| Ladenburg Thalmann Financial Services | 0.1 | $442k | 112k | 3.95 | |
| Lexicon Pharmaceuticals | 0.0 | $216k | 237k | 0.91 |
